{"id":"W2079270178","doi":"10.1200/jco.2002.12.047","title":"Phase I and Pharmacokinetic Study of Novel <scp>l</scp>-Nucleoside Analog Troxacitabine Given as a 30-Minute Infusion Every 21 Days","year":2002,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Rash; Toxicity; Nausea; Pharmacokinetics; Dysgeusia; Gastroenterology; Pharmacology; Adverse effect; Nucleoside analogue; Internal medicine; Nucleoside","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005641128,0.0008897387,0.001278883,0.0002085625,0.000307272,0.0005950551,0.0005546691,0.0007019911,0.002363667],"category_scores_gemma":[0.0003607726,0.0003342869,0.0005438993,0.0002772015,0.0005559365,0.0005053349,0.0002054856,0.001841813,0.0005450023],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009332742,"about_ca_system_score_gemma":0.001276526,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009682697,"about_ca_topic_score_gemma":0.00206981,"domain_scores_codex":[0.9997622,0.0000907397,0.00001126558,0.00005644913,0.00002856847,0.00005059546],"domain_scores_gemma":[0.9997279,0.00003574747,0.00008107755,0.00002501515,0.00001932564,0.0001109606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2298993,0.07011864,0.01037288,0.001347298,0.001198318,0.001131794,0.0006085402,0.008207971,0.5067734,0.0005598019,0.007216522,0.1625654],"study_design_scores_gemma":[0.1255254,0.7892488,0.02349218,0.0000664922,0.0004095268,0.002008619,0.00009688741,0.003748257,0.04627318,0.0002111967,0.008876537,0.00004297033],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945398,0.001443643,0.000860525,0.0001553555,0.00003472663,0.001176237,0.0004351477,0.00008456299,0.001270041],"genre_scores_gemma":[0.9928877,0.001165566,0.001780027,0.0003531357,0.00005928361,0.001118168,0.00113977,0.00003303061,0.001463452],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002363667,"threshold_uncertainty_score":0.007907212,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1574702085339948,"score_gpt":0.4756614697979143,"score_spread":0.3181912612639195,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}